Trial Profile
An Exploratory, Randomized, Placebo Controlled, Double Blind, Parallel Arm Dose Ranging Study to Determine the Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Cough
- Focus Therapeutic Use
- Sponsors Avalo Therapeutics; Cerecor
- 10 Apr 2014 New trial record